Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bio-Kult in Diarrhea-predominant IBS
NCT03251625Phase 4Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Apr 2015
- Primary completion
- Apr 2016
- Modality
- Live Biotherapeutic Products
01
Overview
Phase 4, randomised, double-blind trial in irritable bowel syndrome (IBS) comparing Bio-Kult with Placebo (2 arms). Primary endpoint: Change in severity and frequency of abdominal pain at 1 year. Started Apr 2015; status: completed.
02
Drugs
bacillus subtilis PXN21
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT03251625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03251625.